SALE
市場調查報告書

再生醫療的全球市場 - 預測和機會:2025年

Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934759
出版日期 內容資訊 英文 117 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

再生醫療的全球市場 - 預測和機會:2025年 Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 117 Pages
簡介

全球再生醫療市場,由於細胞、組織、內臟器官的修復及置換或再生的使用增加,預計到2025年以兩位數的年複合成長率成長。再加上慢性的疾病和遺傳疾病的高發生率,幹細胞技術的出現,高齡化人口增加等,是帶動再生醫療市場的重要要素的一部分。

再生醫療,是為了回復、確立正常功能,置換,操作或再生人或動物的細胞,組織或內臟器官的處理流程。還用於為永久損壞的器官創建解決方案。這些醫療還用於關節炎和糖尿病之類幾個不能治療病症的治療。

本報告提供全球再生醫療市場相關調查分析,市場規模、佔有率、預測,各市場區隔分析,競爭分析,市場趨勢的變化,新興機會相關的系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19 (新型冠狀病毒感染疾病)對全球再生醫療市場的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球再生醫療市場預測

  • 市場規模與預測
  • 市場佔有率與預測

第7章 北美的再生醫療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第8章 歐洲的再生醫療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第9章 亞太地區的再生醫療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第10章 中東、非洲的再生醫療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析

第11章 南美的再生醫療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與趨勢

第14章 競爭情形

第15章 策略性建議

第16章 出版社和免責聲明

目錄
Product Code: 4685

Global regenerative medicine market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The global regenerative medicine market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases. Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the global regenerative medicine market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global regenerative medicine market.
  • To classify and forecast global regenerative medicine market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
  • To identify drivers and challenges for global regenerative medicine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global regenerative medicine market.
  • To conduct pricing analysis for global regenerative medicine market.
  • To identify and analyze the profile of leading players operating in global regenerative medicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global regenerative medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Regenerative medicine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to regenerative medicines
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Therapy:

Cell-Based Immunotherapy & Cell Therapy

Gene Therapy

Tissue-Engineering

Immunomodulation Therapy

Blood Transfusion

Bone Marrow Transplantation

Plasma Rich Plasma Therapy

Prolotherapy

Others

  • Market, By Application:

Musculoskeletal Disorders

Wound Care

Oncology

Neurology

Ocular Disorders

Diabetes

Cardiology

Others

  • Market, By Material:

Synthetic Material

  • Biodegradable Synthetic Polymers
  • Scaffold
  • Artificial Vascular Graft Materials
  • Hydrogel Materials

Biologically Derived Material

  • Collagen
  • Xenogeneic Material

Genetically Engineered Material

  • Genetically Manipulated Cells
  • 3D Polymer Technology
  • Transgenic
  • Fibroblast
  • Neural Stem Cells
  • Gene-activated Matrices

Pharmaceutical

  • Small Molecules
  • Biologics
  • Market, By Cell:

Autologous

Allogenic

  • Market, By Product:

Biologic

Cell -based Medical Devices

Biopharmaceutical

Biomaterial

  • Market, By Technique:

Microfracture

Mosaicplasty

  • Market, By Distribution Channel:

Hospitals

Clinics

Online

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global regenerative medicine market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Regenerative Medicine Market

4. Executive Summary

5. Voice of Customer

6. Global Regenerative Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)
    • 6.2.2. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)
    • 6.2.3. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)
      • 6.2.3.1. By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)
      • 6.2.3.2. By Biologically Derived Material (Collagen, Xenogeneic Material)
      • 6.2.3.3. By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)
      • 6.2.3.4. By Pharmaceutical (Small Molecules, Biologics)
    • 6.2.4. By Cell (Autologous, Allogenic)
    • 6.2.5. By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)
    • 6.2.6. By Technique (Microfracture, Mosaicplasty)
    • 6.2.7. By Distribution Channel (Hospitals, Clinics, Online, Others)
    • 6.2.8. By Region
    • 6.2.9. By Company

7. North America Regenerative Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy
    • 7.2.2. By Application
    • 7.2.3. By Material
    • 7.2.4. By Cell
    • 7.2.5. By Product
    • 7.2.6. By Technique
    • 7.2.7. By Distribution Channel
    • 7.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Regenerative Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Material
        • 7.3.1.2.4. By Cell
        • 7.3.1.2.5. By Product
        • 7.3.1.2.6. By Technique
        • 7.3.1.2.7. By Distribution Channel
    • 7.3.2. Canada Regenerative Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Material
        • 7.3.2.2.4. By Cell
        • 7.3.2.2.5. By Product
        • 7.3.2.2.6. By Technique
        • 7.3.2.2.7. By Distribution Channel
    • 7.3.3. Mexico Regenerative Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Material
        • 7.3.3.2.4. By Cell
        • 7.3.3.2.5. By Product
        • 7.3.3.2.6. By Technique
        • 7.3.3.2.7. By Distribution Channel

8. Europe Regenerative Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy
    • 8.2.2. By Application
    • 8.2.3. By Material
    • 8.2.4. By Cell
    • 8.2.5. By Product
    • 8.2.6. By Technique
    • 8.2.7. By Distribution Channel
    • 8.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Regenerative Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Material
        • 8.3.1.2.4. By Cell
        • 8.3.1.2.5. By Product
        • 8.3.1.2.6. By Technique
        • 8.3.1.2.7. By Distribution Channel
    • 8.3.2. Germany Regenerative Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Material
        • 8.3.2.2.4. By Cell
        • 8.3.2.2.5. By Product
        • 8.3.2.2.6. By Technique
        • 8.3.2.2.7. By Distribution Channel
    • 8.3.3. United Kingdom Regenerative Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapy
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Material
        • 8.3.3.2.4. By Cell
        • 8.3.3.2.5. By Product
        • 8.3.3.2.6. By Technique
        • 8.3.3.2.7. By Distribution Channel
    • 8.3.4. Italy Regenerative Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Material
        • 8.3.4.2.4. By Cell
        • 8.3.4.2.5. By Product
        • 8.3.4.2.6. By Technique
        • 8.3.4.2.7. By Distribution Channel
    • 8.3.5. Spain Regenerative Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Material
        • 8.3.5.2.4. By Cell
        • 8.3.5.2.5. By Product
        • 8.3.5.2.6. By Technique
        • 8.3.5.2.7. By Distribution Channel

9. Asia-Pacific Regenerative Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy
    • 9.2.2. By Application
    • 9.2.3. By Material
    • 9.2.4. By Cell
    • 9.2.5. By Product
    • 9.2.6. By Technique
    • 9.2.7. By Distribution Channel
    • 9.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. South Korea Regenerative Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Material
        • 9.3.1.2.4. By Cell
        • 9.3.1.2.5. By Product
        • 9.3.1.2.6. By Technique
        • 9.3.1.2.7. By Distribution Channel
    • 9.3.2. China Regenerative Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Material
        • 9.3.2.2.4. By Cell
        • 9.3.2.2.5. By Product
        • 9.3.2.2.6. By Technique
        • 9.3.2.2.7. By Distribution Channel
    • 9.3.3. Japan Regenerative Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Material
        • 9.3.3.2.4. By Cell
        • 9.3.3.2.5. By Product
        • 9.3.3.2.6. By Technique
        • 9.3.3.2.7. By Distribution Channel
    • 9.3.4. India Regenerative Medicine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value & Volume
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapy
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By Material
        • 9.3.4.2.4. By Cell
        • 9.3.4.2.5. By Product
        • 9.3.4.2.6. By Technique
        • 9.3.4.2.7. By Distribution Channel
    • 9.3.5. Australia Regenerative Medicine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value & Volume
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapy
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By Material
        • 9.3.5.2.4. By Cell
        • 9.3.5.2.5. By Product
        • 9.3.5.2.6. By Technique
        • 9.3.5.2.7. By Distribution Channel

10. Middle East and Africa Printing Ink Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy
    • 10.2.2. By Application
    • 10.2.3. By Material
    • 10.2.4. By Cell
    • 10.2.5. By Product
    • 10.2.6. By Technique
    • 10.2.7. By Distribution Channel
    • 10.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Regenerative Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Material
        • 10.3.1.2.4. By Cell
        • 10.3.1.2.5. By Product
        • 10.3.1.2.6. By Technique
        • 10.3.1.2.7. By Distribution Channel
    • 10.3.2. Saudi Arabia Regenerative Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Material
        • 10.3.2.2.4. By Cell
        • 10.3.2.2.5. By Product
        • 10.3.2.2.6. By Technique
        • 10.3.2.2.7. By Distribution Channel
    • 10.3.3. UAE Regenerative Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Material
        • 10.3.3.2.4. By Cell
        • 10.3.3.2.5. By Product
        • 10.3.3.2.6. By Technique
        • 10.3.3.2.7. By Distribution Channel

11. South America Regenerative Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapy
    • 11.2.2. By Application
    • 11.2.3. By Material
    • 11.2.4. By Cell
    • 11.2.5. By Product
    • 11.2.6. By Technique
    • 11.2.7. By Distribution Channel
    • 11.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Regenerative Medicine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value & Volume
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapy
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Material
        • 11.3.1.2.4. By Cell
        • 11.3.1.2.5. By Product
        • 11.3.1.2.6. By Technique
        • 11.3.1.2.7. By Distribution Channel
    • 11.3.2. Argentina Regenerative Medicine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value & Volume
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapy
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Material
        • 11.3.2.2.4. By Cell
        • 11.3.2.2.5. By Product
        • 11.3.2.2.6. By Technique
        • 11.3.2.2.7. By Distribution Channel
    • 11.3.3. Colombia Regenerative Medicine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value & Volume
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapy
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Material
        • 11.3.3.2.4. By Cell
        • 11.3.3.2.5. By Product
        • 11.3.3.2.6. By Technique
        • 11.3.3.2.7. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Novartis AG
    • 14.2.2. Vericel
    • 14.2.3. Integra Lifesciences
    • 14.2.4. Mimedx Group
    • 14.2.5. Stryker
    • 14.2.6. Wright Medical
    • 14.2.7. Roche
    • 14.2.8. Bristol-Myers Squibb
    • 14.2.9. Allergan
    • 14.2.10. Corline Biomedical
    • 14.2.11. Cook Biotech
    • 14.2.12. Pfizer
    • 14.2.13. Baxter
    • 14.2.14. Boehringer Ingelheim
    • 14.2.15. Caladrius Biosciences
    • 14.2.16. Takara Bio
    • 14.2.17. Medtronic
    • 14.2.18. Osiris Therapeutics
    • 14.2.19. Kite Pharma
    • 14.2.20. Organogenesis

15. Strategic Recommendations

16. About Us and Disclaimer